Ding Shi - Search Results

Year	Number of Results
2003	1
2004	1
2005	3
2006	3
2007	2
2008	1
2009	6
2010	2
2011	5
2012	4
2013	4
2014	6
2015	5
2016	8
2017	8
2018	14
2019	12
2020	16
2021	12
2022	18
2023	8
2024	0

1

Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids.

Wu W, Kaicen W, Bian X, Yang L, Ding S, Li Y, Li S, Zhuge A, Li L. Wu W, et al. Among authors: ding s. Microb Biotechnol. 2023 Oct;16(10):1924-1939. doi: 10.1111/1751-7915.14293. Epub 2023 Jun 28. Microb Biotechnol. 2023. PMID: 37377410 Free PMC article.

2

The Role of FTO in Tumors and Its Research Progress.

Wei H, Li Z, Liu F, Wang Y, Ding S, Chen Y, Liu J. Wei H, et al. Among authors: ding s. Curr Med Chem. 2022;29(5):924-933. doi: 10.2174/0929867328666210714153046. Curr Med Chem. 2022. PMID: 34269659 Review.

3

Advances in Drug Therapy for Systemic Lupus Erythematosus.

Zhao X, Zhang J, Liang Y, Li J, Ding S, Wang Y, Chen Y, Liu J. Zhao X, et al. Among authors: ding s. Curr Med Chem. 2021;28(6):1251-1268. doi: 10.2174/0929867327666200625150408. Curr Med Chem. 2021. PMID: 32586244 Review.

4

Advances in Drug Therapy for Gastrointestinal Stromal Tumour.

Liu J, Li J, Zhu Y, Jing R, Ding S, Zhang J, Zhao L, Chen Y, Shen J. Liu J, et al. Among authors: ding s. Curr Med Chem. 2023 May 5. doi: 10.2174/0929867330666230505163151. Online ahead of print. Curr Med Chem. 2023. PMID: 37151058

5

Editorial: Manipulation of gut microbiota as a key target to intervene on the onset and progression of digestive system diseases.

Shi D, Turroni S, Gong L, Wu W, Yim HCH. Shi D, et al. Front Med (Lausanne). 2022 Aug 29;9:999005. doi: 10.3389/fmed.2022.999005. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36106327 Free PMC article. No abstract available.

6

Research Progress on Small Molecules Inhibitors Targeting TRK Kinases.

Liu J, Zhang Y, Zhu Y, Tian L, Tang M, Shen J, Chen Y, Ding S. Liu J, et al. Among authors: ding s. Curr Med Chem. 2023;30(10):1175-1192. doi: 10.2174/0929867329666220801145639. Curr Med Chem. 2023. PMID: 35927900

7

Effect of Hsp90 Inhibitor KW-2478 on HepG2 Cells.

Chang X, Zhao X, Wang J, Ding S, Xiao L, Zhao E, Zheng X. Chang X, et al. Among authors: ding s. Anticancer Agents Med Chem. 2019;19(18):2231-2242. doi: 10.2174/1871520619666191023094610. Anticancer Agents Med Chem. 2019. PMID: 31642416

8

Application and SARs of Pyrazolo[1,5-a]pyrimidine as Antitumor Agents Scaffold.

Zhang Y, Wen D, Shen J, Tian L, Zhu Y, Zhang J, Zhao L, Ding S, Liu J, Chen Y. Zhang Y, et al. Among authors: ding s. Curr Top Med Chem. 2023;23(12):1043-1064. doi: 10.2174/1568026623666230228111629. Curr Top Med Chem. 2023. PMID: 36852801

9

Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome.

Wu J, Man D, Shi D, Wu W, Wang S, Wang K, Li Y, Yang L, Bian X, Wang Q, Li L. Wu J, et al. Among authors: shi d. Nutrients. 2022 Dec 14;14(24):5311. doi: 10.3390/nu14245311. Nutrients. 2022. PMID: 36558471 Free PMC article.

10

Research Progress on the Drug Resistance of ALK Kinase Inhibitors.

Li Z, Liu F, Wu S, Ding S, Chen Y, Liu J. Li Z, et al. Among authors: ding s. Curr Med Chem. 2022;29(14):2456-2475. doi: 10.2174/0929867328666210806120347. Curr Med Chem. 2022. PMID: 34365942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year